TORONTO (Reuters) - Canadian pharmaceuticals billionaire Barry Sherman failed to implement a succession plan at his Apotex business before his death last week, two business associates told Reuters, potentially leaving it vulnerable to takeover approaches.

Succession doubts cloud Apotex future after billionaire owner's death
Read More
Bagikan Berita Ini
0 Response to "Succession doubts cloud Apotex future after billionaire owner's death"
Posting Komentar